R&D expense · 2012–2025
Healthequity R&D expense
$263M+9.6% · FY2025
Healthequity (HQY) reported $263M in R&D expense for fiscal 2025, +9.6% year on year.
| Fiscal year | R&D expense | Change | Filing |
|---|---|---|---|
| FY20252026-01-31 | $263M | +9.6% | Open → |
| FY20242025-01-31 | $240M | +9.5% | Open → |
| FY20232024-01-31 | $219M | +13.2% | Open → |
| FY20222023-01-31 | $193M | +22.9% | Open → |
| FY20212022-01-31 | $157M | +26.1% | Open → |
| FY20202021-01-31 | $125M | +60.9% | Open → |
| FY20192020-01-31 | $77.6M | +121.3% | Open → |
| FY20182019-01-31 | $35.1M | +28.0% | Open → |
| FY20172018-01-31 | $27.4M | +22.4% | Open → |
| FY20162017-01-31 | $22.4M | +32.9% | Open → |
| FY20152016-01-31 | $16.8M | +60.3% | Open → |
| FY20142015-01-31 | $10.5M | +47.0% | Open → |
| FY20132014-01-31 | $7.1M | +68.9% | Open → |
| FY20122013-01-31 | $4.2M | — | Open → |
R&D expense — Research and development expense is what the company charged to R&D in the income statement for the year. Most companies report no R&D at all — the line is absent rather than zero — so this ranking covers the roughly 40% of filers that do.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2012–2025 compound annual growth +37.4%
R&D expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Healthequity R&D expense |url=https://companiesranked.com/en/company/healthequity/research-and-development-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Healthequity R&D expense. CompaniesRanked. https://companiesranked.com/en/company/healthequity/research-and-development-expenseBibTeX
@misc{companiesranked-en-company-healthequity-research-and-development-expense-2026,
author = {{CompaniesRanked}},
title = {{Healthequity R\&D expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/healthequity/research-and-development-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001428336-26-000010 · March 17, 2026
{{cite web |title=Healthequity R&D expense — 10-K (0001428336-26-000010) |url=https://www.sec.gov/Archives/edgar/data/1428336/000142833626000010/hqy-20260131.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-17}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.